Literature DB >> 15699325

Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.

Jeonghee Cho1, Philip N Tsichlis.   

Abstract

The serine-threonine protein kinase encoded by the Tpl2 protooncogene transduces Toll-like and death receptor signals in a variety of cell types and plays an important role in innate immunity and inflammation. Differential translational initiation of the Tpl2 mRNA gives rise to 58-kDa (p58) and 52-kDa (p52) isoforms. In unstimulated cells, both isoforms are stabilized and inactivated by stoichiometric binding to NF-kappaB1/p105. After lipopolysaccharide or TNF-alpha stimulation, p58 is released from p105 preferentially relative to p52. The released p58 is active but unstable and undergoes rapid degradation via the proteasome. Recent studies revealed that Tpl2 undergoes phosphorylation at Thr-290 and that phosphorylation at this site is required for activation. Here, we present evidence showing that it is the p58 isoform that is preferentially phosphorylated at Thr-290 and that phosphorylation is more efficient when p58 is complexed to p52. Because p58 is preferentially released from p105 after stimulation, we examined whether Tpl2 phosphorylation at this site controls the dissociation of the two proteins in response to external signals and the subsequent events leading to the activation of Tpl2. The results showed that lipopolysaccharide-induced Tpl2 phosphorylation at Thr-290 in macrophages promotes the release of Tpl2 from p105, contributes to the enzymatic activation of the Tpl2 kinase, and is required for the degradation of Tpl2 via the proteasome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699325      PMCID: PMC548980          DOI: 10.1073/pnas.0409856102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis.

Authors:  K M Erny; J Peli; J F Lambert; V Muller; H Diggelmann
Journal:  Oncogene       Date:  1996-11-07       Impact factor: 9.867

2.  Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.

Authors:  C Tsatsanis; C Patriotis; P N Tsichlis
Journal:  Oncogene       Date:  1998-11-19       Impact factor: 9.867

3.  Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.

Authors:  A Salmeron; T B Ahmad; G W Carlile; D Pappin; R P Narsimhan; S C Ley
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

4.  The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases.

Authors:  X Lin; E T Cunningham; Y Mu; R Geleziunas; W C Greene
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

5.  Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation.

Authors:  J D Ceci; C P Patriotis; C Tsatsanis; A M Makris; R Kovatch; D A Swing; N A Jenkins; P N Tsichlis; N G Copeland
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

6.  The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines.

Authors:  C Tsatsanis; C Patriotis; S E Bear; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation.

Authors:  C Patriotis; A Makris; S E Bear; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation.

Authors:  M Aoki; F Hamada; T Sugimoto; S Sumida; T Akiyama; K Toyoshima
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

9.  TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.

Authors:  M P Belich; A Salmerón; L H Johnston; S C Ley
Journal:  Nature       Date:  1999-01-28       Impact factor: 49.962

10.  Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators.

Authors:  R Donald; D W Ballard; J Hawiger
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

View more
  24 in total

1.  NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity.

Authors:  Mei Xu; Rachel A Katzenellenbogen; Carla Grandori; Denise A Galloway
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation.

Authors:  Irene Soria-Castro; Agnieszka Krzyzanowska; Marta López Pelaéz; Javier Regadera; Gema Ferrer; Lluis Montoliu; Rosario Rodríguez-Ramos; Margarita Fernández; Susana Alemany
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

3.  Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling.

Authors:  Teneema Kuriakose; Balázs Rada; Wendy T Watford
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

4.  The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold.

Authors:  Sascha Gutmann; Alexandra Hinniger; Gabriele Fendrich; Peter Drückes; Sylvie Antz; Henri Mattes; Henrik Möbitz; Silvio Ofner; Niko Schmiedeberg; Aleksandar Stojanovic; Sebastien Rieffel; André Strauss; Thomas Troxler; Ralf Glatthar; Helmut Sparrer
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

5.  ABIN2 Function Is Required To Suppress DSS-Induced Colitis by a Tpl2-Independent Mechanism.

Authors:  Sambit K Nanda; Tsunehisa Nagamori; Mark Windheim; Sylvia Amu; Gabriella Aviello; Janet Patterson-Kane; J Simon C Arthur; Steven C Ley; Padraic Fallon; Philip Cohen
Journal:  J Immunol       Date:  2018-10-24       Impact factor: 5.422

6.  A TPL2 (MAP3K8) disease-risk polymorphism increases TPL2 expression thereby leading to increased pattern recognition receptor-initiated caspase-1 and caspase-8 activation, signalling and cytokine secretion.

Authors:  Matija Hedl; Clara Abraham
Journal:  Gut       Date:  2015-07-27       Impact factor: 23.059

7.  Phosphorylation of TPL-2 on serine 400 is essential for lipopolysaccharide activation of extracellular signal-regulated kinase in macrophages.

Authors:  M J Robinson; S Beinke; A Kouroumalis; P N Tsichlis; S C Ley
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

Review 8.  Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase.

Authors:  Thorsten Gantke; Srividya Sriskantharajah; Steven C Ley
Journal:  Cell Res       Date:  2010-12-07       Impact factor: 25.617

9.  KinView: a visual comparative sequence analysis tool for integrated kinome research.

Authors:  Daniel Ian McSkimming; Shima Dastgheib; Timothy R Baffi; Dominic P Byrne; Samantha Ferries; Steven Thomas Scott; Alexandra C Newton; Claire E Eyers; Krzysztof J Kochut; Patrick A Eyers; Natarajan Kannan
Journal:  Mol Biosyst       Date:  2016-11-15

10.  IκB kinase-induced interaction of TPL-2 kinase with 14-3-3 is essential for Toll-like receptor activation of ERK-1 and -2 MAP kinases.

Authors:  Abduelhakem Ben-Addi; Agnes Mambole-Dema; Christine Brender; Stephen R Martin; Julia Janzen; Sven Kjaer; Stephen J Smerdon; Steven C Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.